Axillary and Epitrochlear Lymph Node Dissection for Melanoma

Sandra L. Wong, Douglas S. Tyler, Charles M. Balch, John F. Thompson, Kelly M. McMasters

Research output: Chapter in Book/Report/Conference proceedingChapter


Indications for regional lymph node dissection in melanoma have evolved over time. Once the decision to proceed with axillary lymph node dissection (ALND) has been made, the goal of the procedure in patients with melanoma is complete resection of all lymph nodes (levels I, II, and III) in the axillary basin, respecting the anatomic relations of the axillary vein, thoracodorsal neurovascular bundle, and long thoracic nerve. Performed properly, ALND offers excellent locoregional disease control with acceptably low morbidity rates. While metastasis to epitrochlear nodes is a rare event, epitrochlear lymph node dissection may similarly be an important component of treatment for melanoma patients.

Original languageEnglish (US)
Title of host publicationCutaneous Melanoma, Sixth Edition
PublisherSpringer International Publishing
Number of pages11
ISBN (Electronic)9783030050702
ISBN (Print)9783030050689
StatePublished - Jan 1 2020
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Axillary and Epitrochlear Lymph Node Dissection for Melanoma'. Together they form a unique fingerprint.

Cite this